1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Postoperative Cognitive Decline: new trials by email Literature Review of Postoperative Cognitive Decline trials Research Report on Postoperative Cognitive Decline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Daridorexant to Prevent Post-cardiotomy Delirium Daridorexant 50 mg, Placebo - Postoperative Cognitive Decline, Postoperative Delirium | Phase 2 | Recruiting | University of Rochester | 80 | 2025-10-14 | 2026-01-07 |
| Daridorexant to Prevent Delirium After Heart Surgery Daridorexant 50 mg, Placebo - POSTOPERATIVE DELIRIUM, POSTOPERATIVE COGNITIVE DECLINE | Phase 2 | Completed | University of Rochester | 11 | 2024-11-11 | 2025-07-11 |
Alzheimer Disease (2) · Cognitive Dysfunction (2) · Delirium (2) · Emergence Delirium (2) · Postoperative Cognitive Complications (2)
Brain Diseases (2) · Central Nervous System Diseases (2) · Cognition Disorders (2) · Confusion (2) · Dementia (2) · Mental Disorders (2) · Nervous System Diseases (2) · Neurobehavioral Manifestations (2) · Neurocognitive Disorders (2) · Neurodegenerative Diseases (2) · Neurologic Manifestations (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Postoperative Complications (2) · Signs and Symptoms (2)
daridorexant (2)
United States (2)